Innate immune responses to hepatitis C virus (Q38086755)

28 August 2017

title

Innate immune responses to hepatitis C virus (English)

1 reference

28 August 2017

1 reference

1 reference

2

Charles M Rice

1 reference

28 August 2017

John W Schoggins

1

1 reference

28 August 2017

publication date

1 January 2013

1 reference

Current Topics in Microbiology and Immunology

28 August 2017

published in

1 reference

28 August 2017

volume

369

1 reference

28 August 2017

page(s)

219-242

1 reference

Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication

28 August 2017

cites work

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1128/JVI.76.24.13001-13014.2002

IL28B genotype is associated with differential expression of intrahepatic interferon-stimulated genes in patients with chronic hepatitis C.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Antiviral suppression vs restoration of RIG-I signaling by hepatitis C protease and polymerase inhibitors

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Interferon signaling and treatment outcome in chronic hepatitis C

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Regulation of hepatitis C virus replication by interferon regulatory factor 1

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Peroxisomes are signaling platforms for antiviral innate immunity

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Virus-induced type I IFN stimulates generation of immunoproteasomes at the site of infection

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Antiviral effects of the interferon-induced protein guanylate binding protein 1 and its interaction with the hepatitis C virus NS5B protein

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

TLR3-dependent upregulation of RIG-I leads to enhanced cytokine production from cells infected with the parainfluenza virus SV5

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Interferon-alpha inhibits hepatitis C virus subgenomic RNA replication by an MxA-independent pathway

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Intracellular innate immune cascades and interferon defenses that control hepatitis C virus

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Hepatitis C virus replication is directly inhibited by IFN-alpha in a full-length binary expression system

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Replication of hepatitis C virus

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Hepatic cell-type specific gene expression better predicts HCV treatment outcome than IL28B genotype

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Dysregulation of innate immunity in hepatitis C virus genotype 1 IL28B-unfavorable genotype patients: impaired viral kinetics and therapeutic response

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Expression of paramyxovirus V proteins promotes replication and spread of hepatitis C virus in cultures of primary human fetal liver cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

VISA is an adapter protein required for virus-triggered IFN-beta signaling

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Hepatitis C virus and liver disease: global transcriptional profiling and identification of potential markers

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

HCV infection induces a unique hepatic innate immune response associated with robust production of type III interferons

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Failure of innate and adaptive immune responses in controlling hepatitis C virus infection

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Viperin inhibits hepatitis C virus replication by interfering with binding of NS5A to host protein hVAP-33

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

The receptor of the type I interferon family

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

The interferon stimulated gene 15 functions as a proviral factor for the hepatitis C virus and as a regulator of the IFN response.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

LGP2 is a positive regulator of RIG-I- and MDA5-mediated antiviral responses

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Hepatitis C virus reveals a novel early control in acute immune response

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Paramyxovirus disruption of interferon signal transduction: STATus report

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Efficient initiation of HCV RNA replication in cell culture

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Complete replication of hepatitis C virus in cell culture

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

MAVS dimer is a crucial signaling component of innate immunity and the target of hepatitis C virus NS3/4A protease

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Characterization of HCV interactions with Toll-like receptors and RIG-I in liver cells.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

The protein kinase IKKepsilon can inhibit HCV expression independently of IFN and its own expression is downregulated in HCV-infected livers

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Control of innate immune signaling and membrane targeting by the Hepatitis C virus NS3/4A protease are governed by the NS3 helix α0.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

The antiviral protein viperin inhibits hepatitis C virus replication via interaction with nonstructural protein 5A

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infection.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Gene expression associated with interferon alfa antiviral activity in an HCV replicon cell line

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Molecular mechanism of signal perception and integration by the innate immune sensor retinoic acid-inducible gene-I (RIG-I).

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Structural Insights into RNA Recognition by RIG-I

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Donor and recipient IL28B polymorphisms in HCV-infected patients undergoing antiviral therapy before and after liver transplantation.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Variants in IL28B in liver recipients and donors correlate with response to peg-interferon and ribavirin therapy for recurrent hepatitis C.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

IL28B genotype effects during early treatment with peginterferon and ribavirin in difficult-to-treat hepatitis C virus infection

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

The RNA helicase Lgp2 inhibits TLR-independent sensing of viral replication by retinoic acid-inducible gene-I.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Hepatitis C virus escape from the interferon regulatory factor 3 pathway by a passive and active evasion strategy

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Identification of type I and type II interferon-induced effectors controlling hepatitis C virus replication.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Mitochondrial-associated endoplasmic reticulum membranes (MAM) form innate immune synapses and are targeted by hepatitis C virus

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Hepatic ISG expression is associated with genetic variation in interleukin 28B and the outcome of IFN therapy for chronic hepatitis C.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

The JAK-STAT pathway at twenty

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Increased susceptibility of Huh7 cells to HCV replication does not require mutations in RIG-I

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Structural basis of RNA recognition and activation by innate immune receptor RIG-I

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Innate host response in primary human hepatocytes with hepatitis C virus infection

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Global transcriptional response to interferon is a determinant of HCV treatment outcome and is modified by race

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

ISG15, a ubiquitin-like interferon-stimulated gene, promotes hepatitis C virus production in vitro: implications for chronic infection and response to treatment

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Host-Specific Response to HCV Infection in the Chimeric SCID-beige/Alb-uPA Mouse Model: Role of the Innate Antiviral Immune Response

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Establishment and Maintenance of the Innate Antiviral Response to West Nile Virus Involves both RIG-I and MDA5 Signaling through IPS-1

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Ifih1 gene dose effect reveals MDA5-mediated chronic type I IFN gene signature, viral resistance, and accelerated autoimmunity

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Double-stranded RNA-induced interferon-beta and inflammatory cytokine production modulated by hepatitis C virus serine proteases derived from patients with hepatic diseases

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Structural basis for the activation of innate immune pattern-recognition receptor RIG-I by viral RNA

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

IL28 variation affects expression of interferon stimulated genes and peg-interferon and ribavirin therapy.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Virus-infection or 5'ppp-RNA activates antiviral signal through redistribution of IPS-1 mediated by MFN1

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Triggering the interferon antiviral response through an IKK-related pathway

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Hepatitis C virus blocks interferon effector function by inducing protein kinase R phosphorylation

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Gene expression profiles in hepatitis C virus (HCV) and HIV coinfection: class prediction analyses before treatment predict the outcome of anti-HCV therapy among HIV-coinfected persons

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

The global burden of hepatitis C

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Analysis of ISG expression in chronic hepatitis C identifies viperin as a potential antiviral effector

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Cytosolic DNA sensors regulating type I interferon induction.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Defective Hepatic Response to Interferon and Activation of Suppressor of Cytokine Signaling 3 in Chronic Hepatitis C

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Novel type I interferon IL-28A suppresses hepatitis C viral RNA replication

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Lack of response to exogenous interferon-α in the liver of chimpanzees chronically infected with hepatitis C virus

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Activation of chemokine and inflammatory cytokine response in hepatitis C virus-infected hepatocytes depends on Toll-like receptor 3 sensing of hepatitis C virus double-stranded RNA intermediates

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Convergent evolution of escape from hepaciviral antagonism in primates

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Interferon-inducible gene expression in chimpanzee liver infected with hepatitis C virus

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

IL28B polymorphisms determine early viral kinetics and treatment outcome in patients receiving peginterferon/ribavirin for chronic hepatitis C genotype 1.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Relationship between the interleukin-28b gene polymorphism and the histological severity of hepatitis C virus-induced graft inflammation and the response to antiviral therapy after liver transplantation

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Immune signaling by RIG-I-like receptors

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

ISG56 and IFITM1 proteins inhibit hepatitis C virus replication

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

New direct-acting antiviral agents for the treatment of hepatitis C virus infection and perspectives

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Robust production of infectious hepatitis C virus (HCV) from stably HCV cDNA-transfected human hepatoma cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Cleavage of mitochondrial antiviral signaling protein in the liver of patients with chronic hepatitis C correlates with a reduced activation of the endogenous interferon system

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

IL-28, IL-29 and their class II cytokine receptor IL-28R

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

5'-Triphosphate RNA is the ligand for RIG-I

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Recognition of nucleic acids by pattern-recognition receptors and its relevance in autoimmunity

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

The impact of IL28B genetic variants on recurrent hepatitis C in liver transplantation: significant lessons from a dual graft case.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Effect of alpha interferon on the hepatitis C virus replicon

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Alpha Interferon Induces Long-Lasting Refractoriness of JAK-STAT Signaling in the Mouse Liver through Induction of USP18/UBP43

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Activation of the unfolded protein response and autophagy after hepatitis C virus infection suppresses innate antiviral immunity in vitro

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Interleukin-28B polymorphisms are associated with histological recurrence and treatment response following liver transplantation in patients with hepatitis C virus infection

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

The interferons: 50 years after their discovery, there is much more to learn

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

IFI16 is an innate immune sensor for intracellular DNA

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Expressional screening of interferon-stimulated genes for antiviral activity against hepatitis C virus replication

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Mitochondrial membrane potential is required for MAVS-mediated antiviral signaling

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

A functional genomic screen reveals novel host genes that mediate interferon-alpha's effects against hepatitis C virus

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virus

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Limited suppression of the interferon-beta production by hepatitis C virus serine protease in cultured human hepatocytes

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Endogenous levels of mRNA for IFNs and IFN-related genes in hepatic biopsies of chronic HCV-infected and non-alcoholic steatohepatitis patients

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Antiviral effect and virus-host interactions in response to alpha interferon, gamma interferon, poly(i)-poly(c), tumor necrosis factor alpha, and ribavirin in hepatitis C virus subgenomic replicons

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Functional and therapeutic analysis of hepatitis C virus NS3.4A protease control of antiviral immune defense

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Association of gene expression involving innate immunity and genetic variation in interleukin 28B with antiviral response

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Nonlinear partial differential equations and applications: Genomic analysis of the host response to hepatitis C virus infection

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Silencing of USP18 potentiates the antiviral activity of interferon against hepatitis C virus infection

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Hepatitis C virus induces interferon-λ and interferon-stimulated genes in primary liver cultures

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Identification of three interferon-inducible cellular enzymes that inhibit the replication of hepatitis C virus

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Distinct antiviral signaling pathways in primary human hepatocytes and their differential disruption by HCV NS3 protease

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Interferon-induced gene expression is a stronger predictor of treatment response than IL28B genotype in patients with hepatitis C.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Alpha interferon induces distinct translational control programs to suppress hepatitis C virus RNA replication

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

MAVS forms functional prion-like aggregates to activate and propagate antiviral innate immune response

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Toll-Like Receptor 3 Mediates Establishment of an Antiviral State against Hepatitis C Virus in Hepatoma Cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Up-regulation of Hedgehog pathway is associated with cellular permissiveness for hepatitis C virus replication.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Interferon type I gene expression in chronic hepatitis C.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

MAVS self-association mediates antiviral innate immune signaling

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Regulation of Interferon Regulatory Factor-3 by the Hepatitis C Virus Serine Protease

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Toll-like receptors and innate immunity

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Changes in gene expression during pegylated interferon and ribavirin therapy of chronic hepatitis C virus distinguish responders from nonresponders to antiviral therapy

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Effect of interferon treatment on serum 2',5'-oligoadenylate synthetase levels in hepatitis C-infected patients

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

A diverse range of gene products are effectors of the type I interferon antiviral response

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/978-3-642-27340-7_9

Identifiers

DOI

10.1007/978-3-642-27340-7_9

1 reference

release_oy77moqb5vbm3fayafvj2exzuu

28 August 2017

Fatcat ID

1 reference

https://api.fatcat.wiki/v0/release/oy77moqb5vbm3fayafvj2exzuu

Fatcat

reference URL

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference